NCT03778242View on ClinicalTrials.gov

Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

March 30, 2022

Study Completion Date

July 1, 2022

Conditions
Cesarean Section Complications
Interventions
DRUG

Topical tranexamic acid

temporary uterine packing with gauze of the dimensions soaked with 2 gm tranexamic diluted in 60ml saline acid

DRUG

normal saline

2 placebo ampoules to TA in 100 ml saline by slow infusion

Trial Locations (1)

81528

Aswan University, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT03778242 - Tranexamic Acid in Pregnant Women Undergoing Cesarean Section. | Biotech Hunter | Biotech Hunter